(Q84633735)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22837483%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

B7-DC-Ig enhances vaccine effect by a novel mechanism dependent on PD-1 expression level on T cell subsets (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22837483%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22837483%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Mikayel Mkrtichyan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22837483%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Yana G Najjar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22837483%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Estella C Raulfs

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22837483%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Linda Liu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22837483%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Solomon Langerman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22837483%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Laurent Ozbun

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22837483%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Samir N Khleif

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22837483%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

language of work or name

English

0 references

publication date

25 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22837483%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

published in

Journal of Immunology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22837483%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

189

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22837483%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22837483%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

2338-2347

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22837483%20AND%20SRC:MED&resulttype=core&format=json

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells

9 February 2020

cites work

1 reference

12 December 2020

Elicitation of T cell responses to histologically unrelated tumors by immunization with the novel cancer-testis antigen, brother of the regulator of imprinted sites

1 reference

12 December 2020

PD-L2 expression extends beyond dendritic cells/macrophages to B1 cells enriched for V(H)11/V(H)12 and phosphatidylcholine binding.

1 reference

12 December 2020

PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors

1 reference

12 December 2020

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

1 reference

12 December 2020

Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide

1 reference

12 December 2020

SIV-specific CD8+ T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection

1 reference

12 December 2020

Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma

1 reference

12 December 2020

Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer

1 reference

12 December 2020

PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1.

1 reference

12 December 2020

PD-L2 is expressed on activated human T cells and regulates their function

1 reference

12 December 2020

A push-pull approach to maximize vaccine efficacy: abrogating suppression with an IL-13 inhibitor while augmenting help with granulocyte/macrophage colony-stimulating factor and CD40L

1 reference

12 December 2020

PD-1 and PD-1 ligands: from discovery to clinical application

1 reference

12 December 2020

Regulatory T cells and tumour immunity - observations in mice and men.

1 reference

12 December 2020

PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells

1 reference

12 December 2020

Co-inhibitory role of T-cell-associated B7-H1 and B7-DC in the T-cell immune response.

1 reference

12 December 2020

Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers

1 reference

12 December 2020

Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes

1 reference

12 December 2020

PD-1 and its ligands in tolerance and immunity

1 reference

12 December 2020

Clinical roles of increased populations of Foxp3+CD4+ T cells in peripheral blood from advanced pancreatic cancer patients

1 reference

12 December 2020

Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell-mediated immunity

1 reference

12 December 2020

Tissue expression of PD-L1 mediates peripheral T cell tolerance.

1 reference

12 December 2020

Blocking programmed death-1 ligand-PD-1 interactions by local gene therapy results in enhancement of antitumor effect of secondary lymphoid tissue chemokine

1 reference

12 December 2020

Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer.

1 reference

12 December 2020

Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target

1 reference

12 December 2020

The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors.

1 reference

12 December 2020

Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity

1 reference

12 December 2020

Cyclophosphamide decreases the number, percentage and the function of CD25+ CD4+ regulatory T cells, which suppress induction of contact hypersensitivity

1 reference

12 December 2020

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

1 reference

12 December 2020

The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors

1 reference

12 December 2020

Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction

1 reference

12 December 2020

Immune-potentiating effects of the chemotherapeutic drug cyclophosphamide

1 reference

12 December 2020

Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells

1 reference

12 December 2020

B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression

1 reference

12 December 2020

Crystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2

1 reference

12 December 2020

Anti-PD-1 synergizes with cyclophosphamide to induce potent anti-tumor vaccine effects through novel mechanisms

1 reference

12 December 2020

CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms

1 reference

12 December 2020

Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion

1 reference

12 December 2020

The PD-1 pathway in tolerance and autoimmunity

1 reference

12 December 2020

B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma

1 reference

12 December 2020

CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative

1 reference

12 December 2020

Programmed death-1 (PD-1):PD-ligand 1 interactions inhibit TCR-mediated positive selection of thymocytes

1 reference

12 December 2020

Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.

1 reference

12 December 2020

Identifiers

DOI

10.4049/JIMMUNOL.1103085

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22837483%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference